Dexcom Inc
Dexcom Inc (DXCM) Unusual Options Activity Today
DXCM options volume power reached 13x on the previous trading day. The highest reading was on the $76 PUT expiring 2026-10-30.
Read more
Checking DXCM unusual options activity helps you spot when traders are making outsized bets on Dexcom Inc before the broader market catches on. Dexcom Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor DXCM unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching DXCM unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking DXCM unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and DXCM unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system.
The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Catalysts rarely arrive without a footprint, and DXCM unusual options activity is often where that footprint shows up first. Our scanner tracks Dexcom Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at DXCM unusual options volume on the call side or chasing put sweeps, Dexcom Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 91.00 | — | 0.90 | 0.90 | 69% | 88 | 7 | 1,257.14% |
| 86.00 | 0.20 | 3.80 | 2.00 | 47% | 5 | 4 | 125.00% |
| 88.00 | — | 1.30 | 1.30 | 53% | 8 | 7 | 114.29% |
| 89.00 | — | 1.50 | 1.50 | 70% | 11 | 12 | 91.67% |
| 87.00 | — | 1.60 | 1.60 | 50% | 13 | 15 | 86.67% |
| 84.00 | — | 0.70 | 0.70 | 50% | 18 | 10 | 180.00% |
| 81.00 | — | 2.30 | 2.30 | 137% | 5 | 3 | 166.67% |
| 82.00 | — | 0.85 | 0.85 | 75% | 16 | 53 | 30.19% |
| 80.00 | — | 0.75 | 0.75 | 89% | 1 | 28 | 3.57% |
| 87.00 | 0.50 | 3.40 | 1.95 | 52% | 1 | 115 | 0.87% |
As of September 28, 2026
Spot unusual options activity before it moves
Track DXCM options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→